D. T. Barry, M. Beitel, C. J. Cutter, D. Joshi, J. Falcioni et al., Conventional and nonconventional pain treatment utilization among opioid dependent individuals with pain seeking methadone maintenance treatment: a needs assessment study, J. Addict. Med, vol.4, pp.81-87, 2010.

D. T. Barry, M. Beitel, B. Garnet, D. Joshi, A. Rosenblum et al., Relations among psychopathology, substance use, and physical pain experiences in methadone-maintained patients, J. Clin. Psychiatry, vol.70, pp.1213-1218, 2009.

D. T. Barry, M. Beitel, D. Joshi, and R. S. Schottenfeld, Pain and substance-related painreduction behaviors among opioid dependent individuals seeking methadone maintenance treatment, Am. J. Addict. Am. Acad. Psychiatr. Alcohol. Addict, vol.18, pp.117-121, 2009.

D. T. Barry, C. J. Cutter, M. Beitel, R. D. Kerns, C. Liong et al., Psychiatric Disorders Among Patients Seeking Treatment for Co-Occurring Chronic Pain and Opioid Use Disorder, 2016.

, J. Clin. Psychiatry, vol.77, pp.1413-1419

C. D. Blinderman, R. Sekine, B. Zhang, M. Nillson, and L. Shaiova, Methadone as an analgesic for patients with chronic pain in methadone maintenance treatment programs (MMTPs), J. Opioid Manag, vol.5, pp.107-114, 2009.

D. Bouhassira, M. Lantéri-minet, N. Attal, B. Laurent, and C. Touboul, Prevalence of chronic pain with neuropathic characteristics in the general population, Pain, vol.136, pp.380-387, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00326893

H. Breivik, B. Collett, V. Ventafridda, R. Cohen, and D. Gallacher, Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment, Eur. J. Pain Lond. Engl, vol.10, pp.287-333, 2006.

P. F. Buckley, Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness, J. Clin. Psychiatry, vol.67, pp.5-9, 2006.

. Centre-d'addictovigilance, Observation des Produits Psychotropes Illicites ou Détournés de leur Utilisation Médicamenteuse (OPPIDUM), 2016.

C. S. Cleeland and K. M. Ryan, Pain assessment: global use of the Brief Pain Inventory, Ann. Acad. Med. Singapore, vol.23, pp.129-138, 1994.

P. Compton, C. P. Canamar, M. Hillhouse, L. , and W. , Hyperalgesia in Heroin Dependent Patients and the Effects of Opioid Substitution Therapy, J. Pain, vol.13, pp.401-409, 2012.

P. Compton, V. C. Charuvastra, L. , and W. , Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent, Drug Alcohol Depend, vol.63, pp.139-146, 2001.

P. Compton and G. F. Gebhart, The neurophysiology of pain in addiction, Principles of Addiction Medicine, pp.901-918, 1998.

B. B. Dennis, M. Bawor, L. Naji, C. K. Chan, J. Varenbut et al., Impact of Chronic Pain on Treatment Prognosis for Patients with Opioid Use Disorder: A Systematic Review and Metaanalysis, Subst. Abuse Res. Treat, vol.9, pp.59-80, 2015.

L. Dhingra, C. Masson, D. C. Perlman, R. M. Seewald, J. Katz et al., Epidemiology of pain among outpatients in methadone maintenance treatment programs, Drug Alcohol Depend, vol.128, pp.161-165, 2013.

R. E. Drake, C. Mercer-mcfadden, K. T. Mueser, G. J. Mchugo, and G. R. Bond, Review of integrated mental health and substance abuse treatment for patients with dual disorders, Schizophr. Bull, vol.24, pp.589-608, 1998.

K. E. Dunn, R. K. Brooner, and M. R. Clark, Severity and interference of chronic pain in methadone-maintained outpatients, Pain Med. Malden Mass, vol.15, pp.1540-1548, 2014.

K. E. Dunn, P. H. Finan, D. A. Tompkins, M. Fingerhood, and E. C. Strain, Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients, Drug Alcohol Depend, vol.157, pp.143-149, 2015.

, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA, 2017.

E. Frauger, C. Moracchini, R. Le-boisselier, D. Braunstein, X. Thirion et al., OPPIDUM surveillance program: 20 years of information on drug abuse in France, Fundam. Clin. Pharmacol, vol.27, pp.672-682, 2013.

M. C. Glenn, N. L. Sohler, J. L. Starrels, J. Maradiaga, J. J. Jost et al., The prevalence of chronic pain and pain-related interference in the Canadian population from 1994 to 2008 -Chronic Diseases and Injuries in Canada -Public Health Agency of Canada, Subst. Abuse, vol.37, pp.387-391, 2011.

J. L. Hay, J. M. White, F. Bochner, A. A. Somogyi, T. J. Semple et al., , 2009.

, Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients, J. Pain Off. J. Am. Pain Soc, vol.10, pp.316-322

R. N. Jamison, J. Kauffman, and N. P. Katz, Characteristics of Methadone Maintenance Patients with Chronic Pain, J. Pain Symptom Manage, vol.19, pp.53-62, 2000.

C. B. Johannes, T. K. Le, X. Zhou, J. A. Johnston, and R. H. Dworkin, The Prevalence of Chronic Pain in United States Adults: Results of an Internet-Based Survey, J. Pain, vol.11, pp.1230-1239, 2010.

P. Karoly and L. S. Ruehlman, Psychosocial aspects of pain-related life task interference: an exploratory analysis in a general population sample, Pain Med. Malden Mass, vol.8, pp.563-572, 2007.

R. L. Nahin, Estimates of pain prevalence and severity in adults: United States, J. Pain Off. J. Am. Pain Soc, vol.16, pp.769-780, 2012.

S. Nielsen, B. Larance, N. Lintzeris, E. Black, R. Bruno et al., Correlates of pain in an in-treatment sample of opioid-dependent people, Drug Alcohol Rev, vol.32, pp.489-494, 2013.

, Tableau de bord annuel des traitements de substitution aux opiacés, Observatoire Français des Drogues et des Toxicomanies (OFDT, 2017.

C. S. Rosen, K. D. Drescher, R. H. Moos, J. W. Finney, R. T. Murphy et al., Sixand ten-item indexes of psychological distress based on the Symptom Checklist-90, Assessment, vol.7, pp.103-111, 2000.

A. Rosenblum and J. H. , PRevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities, JAMA, vol.289, pp.2370-2378, 2003.

S. Ross, Chronic pain, mental health and substance use disorders: How can we manage this triad in our healthcare system and in our communities? Columbia, Med. Rev, vol.1, 2017.

S. R. Savage, K. L. Kirsh, and S. D. Passik, Challenges in Using Opioids to Treat Pain in Persons With Substance Use Disorders, Addict. Sci. Clin. Pract, vol.4, pp.4-25, 2008.

D. Schopflocher, P. Taenzer, J. , and R. , The prevalence of chronic pain in Canada, Pain Res. Manag. J. Can. Pain Soc, vol.16, pp.445-450, 2011.

B. St-marie, Health care experiences when pain and substance use disorder coexist: "just because i'm an addict doesn't mean i don't have pain, Pain Med. Malden Mass, vol.15, pp.2075-2086, 2014.

M. D. Stein, D. S. Herman, G. L. Bailey, J. Straus, B. J. Anderson et al., , 2015.

, Chronic Pain and DepressionAmong Primary Care Patients Treated with Buprenorphine, J. Gen. Intern. Med, vol.30, pp.935-941

J. A. Trafton, E. M. Oliva, D. A. Horst, J. D. Minkel, and K. Humphreys, Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment, Drug Alcohol Depend, vol.73, pp.23-31, 2004.

P. Voon, K. Hayashi, M. Milloy, P. Nguyen, E. Wood et al., Pain Among High-Risk Patients on Methadone Maintenance Treatment, J. Pain Off. J. Am. Pain Soc, vol.16, pp.887-894, 2015.

Z. Zahari, C. S. Lee, M. A. Ibrahim, N. Musa, M. A. Mohd-yasin et al., Comparison of Pain Tolerance between Opioid Dependent Patients on Methadone Maintenance Therapy (MMT) and Opioid Naive Individuals, J. Pharm. Pharm. Sci. Publ. Can. Soc. Pharm. Sci. Soc. Can. Sci. Pharm, vol.19, pp.127-136, 2016.

, Après appariement, 67 173 patients ont été inclus dans les groupes « MSO » et « population générale ». La moyenne d'âge

, ? Caractéristiques des patients douloureux chroniques non cancéreux Au total, 8 499 patients douloureux chroniques ont été identifiés dans le groupe MSO et

. Dans-le-groupe and . Mso, , vol.68

, Comparativement au groupe « population générale », les patients du groupe « MSO » étaient plus âgés et plus souvent du genre masculin, avaient plus de co-infections par le VIH et le VHC, étaient plus fréquemment dépendants à l'alcool et présentaient plus

, * Comparaison entre les patients DCNC TSO et population générale

, Tableau 19 : caractéristiques des patients douloureux chroniques non cancéreux dans les groupes MSO et « population générale ». ? Prescriptions d'antalgiques opioïdes Parmi les patients douloureux chroniques

A. Goodman, Addiction: definition and implications, British Journal of Addiction, vol.85, issue.11, pp.1403-1411, 1990.

, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), European Drug Report, 2019.

D. Sur,

L. Amato, S. Minozzi, M. Davoli, and S. Vecchi, Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence, Cochrane Database Syst Rev, issue.10, p.4147, 2011.

M. De-ducla, A. Gagnon, A. Mucchielli, R. S. Vellay, and A. , Follow-up of opioid addicts treated with high-dose buprenorphine in a health care network. National retrospective study

, Ann Med Interne (Paris). avr, vol.151, pp.27-32, 2000.

R. P. Mattick, C. Breen, J. Kimber, and M. Davoli, Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence, Cochrane Database Syst Rev. 6 févr, issue.2, p.2207, 2014.

R. P. Mattick, C. Breen, J. Kimber, and M. Davoli, Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence, Cochrane Database Syst Rev. 8 juill, issue.3, p.2209, 2009.

L. Gowing, M. Farrell, R. Bornemann, L. Sullivan, and R. Ali, Substitution treatment of injecting opioid users for prevention of HIV infection, Cochrane Database Syst Rev. 16 avr, issue.2, p.4145, 2008.

J. L. Sorensen and A. L. Copeland, Drug abuse treatment as an HIV prevention strategy: a review, Drug Alcohol Depend. 1 avr, vol.59, issue.1, pp.17-31, 2000.

K. A. Dolan, J. Shearer, B. White, J. Zhou, J. Kaldor et al., Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection, Addiction. juin, vol.100, issue.6, pp.820-828, 2005.

B. Larance, L. Degenhardt, N. Lintzeris, A. Winstock, and R. Mattick, Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behaviours, Drug Alcohol Rev. mai, vol.30, issue.3, pp.236-281, 2011.

R. A. Sansone and L. A. Sansone, Doctor shopping: a phenomenon of many themes, Innov Clin Neurosci, vol.9, pp.42-48, 2012.

S. M. Smith, R. C. Dart, N. P. Katz, F. Paillard, E. H. Adams et al., Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain, vol.154, pp.2287-96, 2013.

J. Reimer, N. Wright, L. Somaini, C. Roncero, I. Maremmani et al., The Impact of Misuse and Diversion of Opioid Substitution Treatment Medicines: Evidence Review and Expert Consensus, Eur Addict Res, vol.22, issue.2, pp.99-106, 2016.

K. E. Dunn, R. K. Brooner, and M. R. Clark, Severity and interference of chronic pain in methadone-maintained outpatients, Pain Med. sept, vol.15, issue.9, pp.1540-1548, 2014.

P. Voon, K. Hayashi, M. Milloy, P. Nguyen, E. Wood et al., Pain Among High-Risk Patients on Methadone Maintenance Treatment, J Pain. sept, vol.16, issue.9, pp.887-94, 2015.

A. Rosenblum, H. Joseph, C. Fong, S. Kipnis, C. Cleland et al., Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities, JAMA. 14 mai, vol.289, issue.18, pp.2370-2378, 2003.

S. Nordmann, A. Vilotitch, C. Lions, L. Michel, M. Mora et al., Pain in methadone patients: Time to address undertreatment and suicide risk (ANRS-Methaville trial), PLoS ONE, vol.12, issue.5, p.176288, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01985280

S. Hines, S. Theodorou, A. Williamson, D. Fong, and K. Curry, Management of acute pain in methadone maintenance therapy in-patients, Drug Alcohol Rev. sept, vol.27, issue.5, pp.519-542, 2008.

S. Cooper, A. J. Robison, and M. S. Mazei-robison, Reward Circuitry in Addiction, Neurotherapeutics. juill, vol.14, issue.3, pp.687-97, 2017.

G. F. Koob and N. D. Volkow, Neurobiology of addiction: a neurocircuitry analysis, Lancet Psychiatry. août, vol.3, issue.8, pp.760-73, 2016.

G. F. Koob, L. Moal, and M. , Drug abuse: hedonic homeostatic dysregulation, Science, vol.278, issue.5335, pp.52-60, 1997.

E. J. Nestler, Is there a common molecular pathway for addiction? Nature Neuroscience, vol.8, p.1445, 2005.

J. Olds and P. Milner, Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain, J Comp Physiol Psychol. déc, vol.47, issue.6, pp.419-446, 1954.

R. A. Wise and M. A. Bozarth, Action of drugs of abuse on brain reward systems: an update with specific attention to opiates, Pharmacol Biochem Behav. août, vol.17, issue.2, pp.239-282, 1982.

R. A. Wise and P. P. Rompre, Brain dopamine and reward, Annu Rev Psychol, vol.40, pp.191-225, 1989.

A. Herz, Opioid reward mechanisms: a key role in drug abuse? Can, J Physiol Pharmacol. 1 mars, vol.76, issue.3, pp.252-260, 1998.

R. Maldonado, Le système opioïde endogène et l'addiction aux drogues, Ann Pharm Fr. janv, vol.68, issue.1, pp.3-11, 2010.

N. Hirose, K. Murakawa, K. Takada, Y. Oi, T. Suzuki et al., Interactions among mu-and delta-opioid receptors, especially putative delta1-and delta2-opioid receptors, promote dopamine release in the nucleus accumbens, Neuroscience, vol.135, issue.1, pp.213-238, 2005.

Y. Yoshida, S. Koide, N. Hirose, K. Takada, K. Tomiyama et al., Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu-and delta-2-opioid receptors, Neuroscience, vol.92, issue.4, pp.1357-65, 1999.

S. W. Johnson and R. A. North, Opioids excite dopamine neurons by hyperpolarization of local interneurons, J Neurosci. févr, vol.12, issue.2, pp.483-491, 1992.

R. F. Mucha, M. J. Millan, and A. Herz, Aversive properties of naloxone in non-dependent (naive) rats may involve blockade of central beta-endorphin, Psychopharmacology (Berl), vol.86, issue.3, pp.281-286, 1985.

R. Bals-kubik, T. S. Shippenberg, and A. Herz, Involvement of central mu and delta opioid receptors in mediating the reinforcing effects of beta-endorphin in the rat, Eur J Pharmacol. 3 janv, vol.175, issue.1, pp.63-72, 1990.

R. Bals-kubik, A. Herz, and T. S. Shippenberg, Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated, Psychopharmacology (Berl), vol.98, issue.2, pp.203-209, 1989.

R. Spanagel, A. Herz, and T. S. Shippenberg, Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway, Proc Natl Acad Sci, vol.89, issue.6, pp.2046-50, 1992.

V. I. Chefer and T. S. Shippenberg, Augmentation of morphine-induced sensitization but reduction in morphine tolerance and reward in delta-opioid receptor knockout mice, Neuropsychopharmacology. mars, vol.34, issue.4, pp.887-98, 2009.

S. B. Floresco, The nucleus accumbens: an interface between cognition, emotion, and action, Annu Rev Psychol. 3 janv, vol.66, pp.25-52, 2015.

J. Tassin, C. Lanteri, and L. Salomon, Uncoupling between noradrenergic and serotonergic neurons: As a mechanism for drug addiction

, Med Sci, vol.22, issue.10, pp.798-800, 2006.

M. Pavuluri, K. Volpe, and A. Yuen, Nucleus Accumbens and Its Role in Reward and Emotional Circuitry: A Potential Hot Mess in Substance Use and Emotional Disorders, vol.4, pp.52-70, 2017.

H. Ritchie and M. Roser, Substance Use. Our World in Data, vol.16, 2018.

D. Sur,

, European Monitoring Centre for Drugs Ans Drugs Addiction (EMCDDA), 2019.

D. Sur,

, tableau de bord annuel « Traitements de substitution aux opioïdes » Mise à jour, Observatoire Français des Drogues et des Toxicomanies (OFDT), vol.19, pp.61-67, 1999.

, AMM chlorhydrate de méthadone, Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 1995.

D. Circulaire and . Dhos, , pp.2002-57, 2002.

D. Sur,

, AMM méthdone gélule, Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 2007.

, Méthadone gélule-Mentions légales, Agence Nationale de Sécurité du Médicament et de la Santé (ANSM), 2008.

D. Sur,

S. L. Walsh and T. Eissenberg, The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic, Drug Alcohol Depend. 21 mai, vol.70, issue.2, pp.13-27, 2003.

, AMM buprénorphine, 1995.

, European Medicine Agency. Suboxone

, European Medicines Agency, 2018.

D. Sur,

, Base de données publique des médicaments. SUBOXONE 2mg/0,5mg. 25 sept, 2006.

D. Sur,

, Base de données publique des médicaments. Suboxone 8mg/2mg. 26 sept, 2006.

D. Sur,

, Base de données publique des médicaments, RCP OROBUPRE

D. Sur,

H. Autorité-de-santé, Commission de transparence -OROBUPRE, vol.25, 2018.

D. Sur,

T. Dr-didier, Buprénorphine à action prolongée, un nouveau souffle pour la prise en charge des usagers d'opioïdes ?, Le courrier des addictions, vol.21, issue.3, pp.11-16, 2019.

B. Johnson and T. Richert, Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities, Harm Reduct J. 2 mai, vol.16, issue.1, p.31, 2019.

M. R. Lofwall and S. L. Walsh, A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world, J Addict Med, vol.8, issue.5, pp.315-341, 2014.

S. Michael, Buprenorphine Use and Risk of Abuse and Diversion, Adv Pharmacoepidemiol Drug Saf, vol.3, p.145, 2014.

H. D. Chilcoat, H. R. Amick, M. R. Sherwood, and K. E. Dunn, Buprenorphine in the United States: Motives for abuse, misuse, and diversion, J Subst Abuse Treat. sept, vol.104, pp.148-57, 2019.

A. Casati, R. Sedefov, and T. Pfeiffer-gerschel, Misuse of Medicines in the European Union: A Systematic Review of the Literature, European Addiction Research, vol.18, issue.5, pp.228-273, 2012.

H. Alho, D. Sinclair, E. Vuori, and A. Holopainen, Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users, Drug Alcohol Depend. 17 avr, vol.88, issue.1, pp.75-83, 2007.

A. R. Bazazi, M. Yokell, J. J. Fu, J. D. Rich, and N. D. Zaller, Illicit Use of Buprenorphine/Naloxone Among Injecting and Noninjecting Opioid Users, J Addict Med. sept, vol.5, issue.3, pp.175-80, 2011.

T. J. Cicero, M. S. Ellis, and H. D. Chilcoat, Understanding the use of diverted buprenorphine, Drug Alcohol Depend. janv, vol.193, pp.117-140, 2018.

P. Duffy and H. Baldwin, The nature of methadone diversion in England: a Merseyside case study, Harm Reduct J. 13 janv, vol.9, p.3, 2012.

E. Moratti, H. Kashanpour, T. Lombardelli, and M. Maisto, Intravenous misuse of buprenorphine: characteristics and extent among patients undergoing drug maintenance therapy, Clin Drug Investig, vol.30, pp.3-11, 2010.

Z. Schuman-olivier, M. Albanese, S. E. Nelson, L. Roland, F. Puopolo et al., Selftreatment: illicit buprenorphine use by opioid-dependent treatment seekers, J Subst Abuse Treat. juill, vol.39, issue.1, pp.41-50, 2010.

B. Johnson and T. Richert, Diversion of methadone and buprenorphine from opioid substitution treatment: The importance of patients' attitudes and norms, J Subst Abuse Treat. juill, vol.54, pp.50-55, 2015.

E. Launonen, H. Alho, E. Kotovirta, I. Wallace, and K. Simojoki, Diversion of opioid maintenance treatment medications and predictors for diversion among Finnish maintenance treatment patients, International Journal of Drug Policy, 2015.

D. Sur,

T. J. Cicero, M. S. Ellis, H. L. Surratt, and S. P. Kurtz, Factors contributing to the rise of buprenorphine misuse, Drug and Alcohol Dependence. sept, vol.142, pp.98-104, 2014.

O. Dale, C. Hoffer, P. Sheffels, and E. D. Kharasch, Disposition of nasal, intravenous, and oral methadone in healthy volunteers, Clin Pharmacol Ther, vol.72, issue.5, pp.536-581, 2002.

C. K. Aitken, P. G. Higgs, and M. E. Hellard, Buprenorphine injection in Melbourne, Australia--an update, Drug Alcohol Rev. mars, vol.27, issue.2, pp.197-206, 2008.

R. A. Jenkinson, N. C. Clark, C. L. Fry, and M. Dobbin, Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?, Addiction. févr, vol.100, issue.2, pp.197-205, 2005.

B. Larance, R. Mattick, R. Ali, N. Lintzeris, R. Jenkinson et al., Diversion and injection of buprenorphine-naloxone film two years post-introduction in Australia, Drug Alcohol Rev. janv, vol.35, issue.1, pp.83-91, 2016.

A. Hakansson, A. Medvedeo, M. Andersson, and M. Berglund, Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration, Eur Addict Res, vol.13, issue.4, pp.207-222, 2007.

J. P. Moatti, D. Vlahov, I. Feroni, V. Perrin, and Y. Obadia, Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France, Eur Addict Res. mars, vol.7, issue.1, pp.40-45, 2001.

Y. Obadia, V. Perrin, I. Feroni, D. Vlahov, and J. P. Moatti, Injecting misuse of buprenorphine among French drug users, Addiction. févr, vol.96, issue.2, pp.267-72, 2001.

S. Darke, J. Ross, and W. Hall, Prevalence and correlates of the injection of methadone syrup in Sydney, Australia. Drug Alcohol Depend. 11 déc, vol.43, issue.3, pp.191-199, 1996.

R. Humeniuk, R. Ali, C. Mcgregor, and S. Darke, Prevalence and correlates of intravenous methadone syrup administration in Adelaide, Australia. Addiction. avr, vol.98, issue.4, pp.413-421, 2003.

J. K. Zhao, A. H. Kral, L. D. Wenger, and R. N. Bluthenthal, Characteristics Associated with Nonmedical Methadone Use among People Who Inject Drugs in California, Subst Use Misuse, pp.1-10, 2019.

B. Larance, L. Degenhardt, N. Lintzeris, J. Bell, A. Winstock et al., Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised dosing, Drug Alcohol Depend, vol.118, issue.2-3, pp.265-73, 2011.

M. Auriacombe, M. Fatséas, J. Dubernet, J. Daulouède, and J. Tignol, French field experience with buprenorphine, Am J Addict, vol.13, issue.1, pp.17-28, 2004.

S. Nordmann, E. Frauger, V. Pauly, V. Orléans, V. Pradel et al., Misuse of buprenorphine maintenance treatment since introduction of its generic forms: OPPIDUM survey, Pharmacoepidemiol Drug Saf. 1 févr, vol.21, issue.2, pp.184-90, 2012.

F. Lugoboni, L. Zamboni, M. Cibin, and S. Tamburin, Intravenous Misuse of Methadone, Buprenorphine and Buprenorphine-Naloxone in Patients Under Opioid Maintenance Treatment: A Cross-Sectional Multicentre Study, Eur Addict Res, vol.25, issue.1, pp.10-19, 2019.

P. Roux, V. Villes, J. Blanche, D. Bry, B. Spire et al., Buprenorphine in primary care: Risk factors for treatment injection and implications for clinical management, Drug and Alcohol Dependence. 1 sept, vol.97, issue.1-2, pp.105-118, 2008.

P. Roux, V. Villes, D. Bry, B. Spire, I. Feroni et al., Buprenorphine sniffing as a response to inadequate care in substituted patients: Results from the Subazur survey in south-eastern France, Addictive Behaviors. déc, vol.33, issue.12, pp.1625-1634, 2008.

G. Vidal-trecan, I. Varescon, N. Nabet, and A. Boissonnas, Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France, Drug and Alcohol Dependence. 1 mars, vol.69, issue.2, pp.175-81, 2003.

X. Thirion, K. Barrau, J. Micallef, F. Haramburu, W. Lowenstein et al.,

, Ann Med Interne (Paris). avr, vol.151, pp.10-17, 2000.

C. Cazorla, D. Grenier-de-cardenal, H. Schuhmacher, L. Thomas, A. Wack et al.,

, Presse Med. 4 juin, vol.34, issue.10, pp.719-743, 2005.

A. Guichard, F. Lert, C. Calderon, H. Gaigi, O. Maguet et al., Illicit drug use and injection practices among drug users on methadone and buprenorphine maintenance treatment in France. Addiction, vol.98, pp.1585-97, 2003.

E. Launonen, I. Wallace, E. Kotovirta, H. Alho, and K. Simojoki, Factors associated with nonadherence and misuse of opioid maintenance treatment medications and intoxicating drugs among Finnish maintenance treatment patients, Drug Alcohol Depend. 1 mai, vol.162, pp.227-262, 2016.

A. E. Chevalley, J. Besson, M. Croquette-krokar, C. Davidson, J. A. Dubois et al., Prevalence of methadone injection in three Swiss cities, Presse Med. 18 juin, vol.34, issue.11, pp.776-80, 2005.

N. Lintzeris, M. Lenné, and A. Ritter, Methadone injecting in Australia: a tale of two cities, Addiction. août, vol.94, issue.8, pp.1175-1183, 1999.

G. Judson, R. Bird, P. O'connor, T. Bevin, R. Loan et al., Drug injecting in patients in New Zealand Methadone Maintenance Treatment programs: an anonymous survey, Drug Alcohol Rev. janv, vol.29, issue.1, pp.41-47, 2010.

D. Horyniak, P. Dietze, B. Larance, A. Winstock, and L. Degenhardt, The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia, International Journal of Drug Policy. mars, vol.22, issue.2, pp.167-71, 2011.

B. Larance, N. Lintzeris, R. Ali, P. Dietze, R. Mattick et al., The diversion and injection of a buprenorphine-naloxone soluble film formulation, Drug Alcohol Depend. 1 mars, vol.136, pp.21-28, 2014.

P. Amato, Clinical experience with fortnightly buprenorphine/naloxone versus buprenorphine in Italy: preliminary observational data in an office-based setting, Clin Drug Investig, vol.30, issue.1, pp.33-42, 2010.

B. Vicknasingam, M. Mazlan, R. S. Schottenfeld, and M. C. Chawarski, Injection of buprenorphine and buprenorphine/naloxone tablets in Malaysia, Drug Alcohol Depend. 1 sept, vol.111, issue.1-2, pp.44-53, 2010.

R. D. Bruce, S. Govindasamy, L. Sylla, A. Kamarulzaman, and F. L. Altice, Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market, Am J Drug Alcohol Abuse, vol.35, issue.2, pp.68-72, 2009.

A. R. Winstock, T. Lea, and J. Sheridan, Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia, Int J Drug Policy. déc, vol.19, issue.6, pp.450-458, 2008.

A. R. Winstock and T. Lea, Diversion and injection of methadone and buprenorphine among clients in public opioid treatment clinics in New South Wales, Australia. Subst Use Misuse, vol.45, issue.1-2, pp.240-52, 2010.

G. Mitchell, S. Kelly, S. M. Brown, B. S. , S. Reisinger et al., Uses of diverted methadone and buprenorphine by opioid-addicted individuals in, Am J Addict, vol.18, issue.5, pp.346-55, 2009.

A. Roche, S. Mccabe, and B. P. Smyth, Illicit methadone use and abuse in young people accessing treatment for opiate dependence, Eur Addict Res, vol.14, issue.4, pp.219-244, 2008.

W. R. Davis and B. D. Johnson, Prescription opioid use, misuse, and diversion among street drug users, Drug Alcohol Depend. 1 janv, vol.92, issue.1-3, pp.267-76, 2008.

H. Reddon, J. Ho, K. Debeck, M. Milloy, Y. Liu et al., Increasing diversion of methadone in Vancouver, Canada, Journal of Substance Abuse Treatment. 1 févr, vol.85, pp.10-16, 2005.

S. Nordmann, V. Pradel, M. Lapeyre-mestre, E. Frauger, V. Pauly et al., Doctor shopping reveals geographical variations in opioid abuse, Pain Physician. janv, vol.16, issue.1, pp.89-100, 2013.

V. Pauly, V. Pradel, L. Pourcel, S. Nordmann, E. Frauger et al., Estimated magnitude of diversion and abuse of opioids relative to benzodiazepines in France. Drug and Alcohol Dependence, vol.126, pp.13-20, 2012.

. Ceip-paca-corse, OPPIDUM -Observatoire des Produits Psychotropes Illicites ou Détournés de leur Utilisation Médicamenteuse, 2018.

D. Sur,

, Observatoire Français des Drogues et des Toxicomanies (OFDT), 2019.

D. Sur,

. Ceip-toulouse, OSIAP -Ordonnances Suspectes Indicateurs d'Abus Possible, 2017.

D. Sur,

M. S. Cepeda, D. Fife, M. A. Kihm, G. Mastrogiovanni, and Y. Yuan, Comparison of the Risks of Shopping Behavior and Opioid Abuse Between Tapentadol and Oxycodone and Association of Shopping Behavior and Opioid Abuse, Clin J Pain. déc, vol.30, issue.12, pp.1051-1057, 2014.

M. S. Cepeda, D. Fife, W. Chow, G. Mastrogiovanni, and S. C. Henderson, Opioid shopping behavior: how often, how soon, which drugs, and what payment method, J Clin Pharmacol. janv, vol.53, issue.1, pp.112-119, 2013.

M. S. Cepeda, D. Fife, L. Vo, G. Mastrogiovanni, and Y. Yuan, Comparison of opioid doctor shopping for tapentadol and oxycodone: a cohort study, J Pain, vol.14, issue.2, pp.158-64, 2013.

Y. Chou, S. Shih, W. Tsai, C. R. Li, K. Xu et al., Improvement of quality of life in methadone treatment patients in northern Taiwan: a follow-up study, BMC Psychiatry. 16 juill, vol.13, p.190, 2013.

A. Dhawan and A. Chopra, Does buprenorphine maintenance improve the quality of life of opioid users?, Indian J Med Res. janv, vol.137, issue.1, pp.130-135, 2013.

J. Bezin, M. Duong, R. Lassalle, C. Droz, A. Pariente et al., The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology, Pharmacoepidemiol Drug Saf. août, vol.26, issue.8, pp.954-62, 2017.

J. A. Boscarino, M. Rukstalis, S. N. Hoffman, J. J. Han, P. M. Erlich et al., Risk factors for drug dependence among out-patients on opioid therapy in a large US healthcare system, Addiction, vol.105, issue.10, pp.1776-82, 2010.

M. J. Edlund, B. C. Martin, M. Fan, A. Devries, J. B. Braden et al., Risks for opioid abuse and dependence among recipients of chronic opioid therapy: Results from the TROUP Study, Drug Alcohol Depend, vol.112, issue.1-2, pp.90-98, 2010.

M. J. Edlund, D. Steffick, T. Hudson, K. M. Harris, and M. Sullivan, Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic noncancer pain, PAIN. juin, vol.129, issue.3, pp.355-62, 2007.

D. Henkel, Unemployment and substance use: a review of the literature, Curr Drug Abuse Rev. mars, vol.4, issue.1, pp.4-27, 1990.

. Iasp, . Part, and . Iii, Pain Terms, A Current List with Definitions and Notes on Usage" Classification of Chronic Pain, Second Edition, IASP Task Force on Taxonomy, 1994.

R. N. Jamison, J. Kauffman, and N. P. Katz, Characteristics of Methadone Maintenance Patients with Chronic Pain, Journal of Pain and Symptom Management. janv, vol.19, issue.1, pp.53-62, 2000.

A. Rosenblum and . Jh, PRevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities, JAMA. 14 mai, vol.289, issue.18, pp.2370-2378, 2003.

D. T. Barry, M. Beitel, D. Joshi, and R. S. Schottenfeld, Pain and substance-related pain-reduction behaviors among opioid dependent individuals seeking methadone maintenance treatment, Am J Addict. avr, vol.18, issue.2, pp.117-138, 2009.

L. Dhingra, C. Masson, D. C. Perlman, R. M. Seewald, J. Katz et al., Epidemiology of pain among outpatients in methadone maintenance treatment programs, Drug Alcohol Depend. 1 févr, vol.128, issue.1-2, pp.161-166, 2013.

D. T. Barry, J. D. Savant, M. Beitel, C. J. Cutter, B. A. Moore et al., Pain and associated substance use among opioid dependent individuals seeking office-based treatment with buprenorphine-naloxone: a needs assessment study, Am J Addict. juin, vol.22, issue.3, pp.212-219, 2013.

S. Nielsen, B. Larance, N. Lintzeris, E. Black, R. Bruno et al., Correlates of pain in an in-treatment sample of opioid-dependent people, Drug Alcohol Rev. sept, vol.32, issue.5, pp.489-94, 2013.

J. A. Trafton, E. M. Oliva, D. A. Horst, J. D. Minkel, and K. Humphreys, Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment, Drug Alcohol Depend. 7 janv, vol.73, issue.1, pp.23-31, 2004.

M. A. Ilgen, J. A. Trafton, and K. Humphreys, Response to methadone maintenance treatment of opiate dependent patients with and without significant pain, Drug Alcohol Depend. 20 mai, vol.82, issue.3, pp.187-93, 2006.

J. S. Potter, A. Chakrabarti, C. P. Domier, M. P. Hillhouse, R. D. Weiss et al., Pain and continued opioid use in individuals receiving buprenorphine-naloxone for opioid detoxification: secondary analyses from the Clinical Trials Network, J Subst Abuse Treat. juin, vol.38, issue.1, pp.80-86, 2010.

J. I. Tsui, M. C. Lira, D. M. Cheng, M. R. Winter, D. P. Alford et al., Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy, Drug Alcohol Depend. 1 sept, vol.166, pp.26-31, 2016.

M. C. Glenn, N. L. Sohler, J. L. Starrels, J. Maradiaga, J. J. Jost et al., Characteristics of methadone maintenance treatment patients prescribed opioid analgesics, Subst Abus, vol.37, issue.3, pp.387-91, 2016.

K. E. Dunn, P. H. Finan, D. A. Tompkins, M. Fingerhood, and E. C. Strain, Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients, Drug Alcohol Depend. 1 déc, vol.157, pp.143-152, 2015.

D. T. Barry, M. Beitel, B. Garnet, D. Joshi, A. Rosenblum et al., Relations among psychopathology, substance use, and physical pain experiences in methadone-maintained patients, J Clin Psychiatry. sept, vol.70, issue.9, pp.1213-1221, 2009.

E. Peles, S. Schreiber, J. Gordon, and M. Adelson, Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain, Pain. févr, vol.113, issue.3, pp.340-346, 2005.

M. D. Stein, D. S. Herman, G. L. Bailey, J. Straus, B. J. Anderson et al., Chronic Pain and DepressionAmong Primary Care Patients Treated with Buprenorphine, J Gen Intern Med. juill, vol.30, issue.7, pp.935-976, 2015.

M. Dueñas, B. Ojeda, A. Salazar, J. A. Mico, and I. Failde, A review of chronic pain impact on patients, their social environment and the health care system, J Pain Res, vol.9, pp.457-67, 2016.

Ó. A. Steingrímsdóttir, T. Landmark, G. J. Macfarlane, and C. S. Nielsen, Defining chronic pain in epidemiological studies -a systematic review and meta-analysis. Pain, 2017.

C. B. Johannes, T. K. Le, X. Zhou, J. A. Johnston, and R. H. Dworkin, The Prevalence of Chronic Pain in United States Adults: Results of an Internet-Based Survey, The Journal of Pain, vol.11, issue.11, pp.1230-1239, 2010.

R. L. Nahin, Estimates of pain prevalence and severity in adults: United States, J Pain. août, vol.16, issue.8, pp.769-80, 2012.

H. Breivik, B. Collett, V. Ventafridda, R. Cohen, and D. Gallacher, Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment, Eur J Pain. mai, vol.10, issue.4, pp.287-333, 2006.

D. Schopflocher, P. Taenzer, and R. Jovey, The prevalence of chronic pain in Canada, Pain Res Manag, vol.16, issue.6, pp.445-50, 2011.

D. Bouhassira, M. Lantéri-minet, N. Attal, B. Laurent, and C. Touboul, Prevalence of chronic pain with neuropathic characteristics in the general population, Pain. juin, vol.136, issue.3, pp.380-387, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00326893

D. T. Barry, C. J. Cutter, M. Beitel, R. D. Kerns, C. Liong et al., Psychiatric Disorders Among Patients Seeking Treatment for Co-Occurring Chronic Pain and Opioid Use Disorder, J Clin Psychiatry, vol.77, issue.10, pp.1413-1422, 2016.

B. B. Dennis, M. Bawor, L. Naji, C. K. Chan, J. Varenbut et al., Impact of Chronic Pain on Treatment Prognosis for Patients with Opioid Use Disorder: A Systematic Review and Meta-analysis, Subst Abuse, vol.9, pp.59-80, 2015.

B. B. Dennis, M. Bawor, J. Paul, C. Plater, G. Pare et al., Pain and Opioid Addiction: A Systematic Review and Evaluation of Pain Measurement in Patients with Opioid Dependence on Methadone Maintenance Treatment, Curr Drug Abuse Rev, vol.9, issue.1, pp.49-60, 2016.

A. Hald, A history of mathematical statistics from 1750 to 1930, series in probability and statistics), vol.795, 1998.

W. G. Cochran, Laplace's Ratio Estimator, Contributions to Survey Sampling and Applied Statistics, pp.3-10, 1978.

Z. E. Schnabel, The Estimation of Total Fish Population of a Lake, The American Mathematical Monthly. juin, vol.45, issue.6, p.348, 1938.

S. E. Fienberg, The Multiple Recapture Census for Closed Populations and Incomplete 2 k Contingency Tables, Biometrika. déc, vol.59, issue.3, p.591, 1972.

J. Wittes and V. W. Sidel, A generalization of the simple capture-recapture model with applications to epidemiological research, J Chronic Dis. août, vol.21, issue.5, pp.287-301, 1968.

J. T. Wittes, Applications of a Multinomial Capture-Recapture Model to Epidemiological Data, Journal of the American Statistical Association. mars, vol.69, issue.345, pp.93-100, 1974.

E. Hook and R. Regal, Capture-recapture methods, The Lancet. mars, vol.339, issue.8795, p.742, 1992.

E. B. Hook and R. R. Regal, Capture-recapture methods in epidemiology: methods and limitations, Epidemiol Rev, vol.17, issue.2, pp.243-64, 1995.

, Capture-recapture and multiple-record systems estimation I: History and theoretical development. International Working Group for Disease Monitoring and Forecasting, Am J Epidemiol, vol.15, issue.10, pp.1047-58, 1995.

, Capture-recapture and multiple-record systems estimation II: Applications in human diseases. International Working Group for Disease Monitoring and Forecasting, Am J Epidemiol, vol.15, issue.10, pp.1059-68, 1995.

S. D. Plouvier, P. Bernillon, K. Ligier, D. Theis, P. Miquel et al., Completeness of a newly implemented general cancer registry in northern France: Application of a threesource capture-recapture method, Rev Epidemiol Sante Publique. juill, vol.67, issue.4, pp.239-245, 2019.

A. Törner, K. Stokkeland, Å. Svensson, P. W. Dickman, R. Hultcrantz et al., The underreporting of hepatocellular carcinoma to the cancer register and a log-linear model to estimate a more correct incidence, Hepatology. mars, vol.65, issue.3, pp.885-92, 2017.

C. M. Cameron, K. J. Coppell, D. J. Fletcher, and K. J. Sharples, Capture-recapture using multiple data sources: estimating the prevalence of diabetes, Aust N Z J Public Health. juin, vol.36, issue.3, pp.223-231, 2012.

N. Van-hest, A. D. Grant, F. Smit, A. Story, and J. H. Richardus, Estimating infectious diseases incidence: validity of capture-recapture analysis and truncated models for incomplete count data. Epidemiology and Infection, 2008.

D. Sur,

J. Gimenez-duran, A. Galmes-truyols, T. Gonzalez-cortijo, M. Portell-arbona, C. Bosch-isabel et al., Capture-recapture and anti-tuberculosis drug prescriptions, Int J Tuberc Lung Dis, vol.22, issue.7, pp.754-763, 2010.

D. Scublinsky, H. Venarotti, G. Citera, O. D. Messina, E. Scheines et al., The prevalence of rheumatoid arthritis in Argentina: a capture-recapture study in a city of Buenos Aires province, J Clin Rheumatol, vol.16, issue.7, pp.317-338, 2010.

A. St, A. O'rourke, R. H. White, K. E. Schneider, M. Kilkenny et al., Estimating the Number of People Who Inject Drugs in A Rural County in Appalachia, Am J Public Health. mars, vol.109, issue.3, pp.445-50, 2019.

T. Akkaya-hocagil, W. Hsu, K. Sommerhalter, C. Mcgarry, and A. Van-zutphen, Utility of Capture-Recapture Methodology to Estimate Prevalence of Congenital Heart Defects Among Adolescents in 11, Birth Defects Res, vol.109, issue.18, pp.1423-1432, 2008.

M. Waller, G. D. Mishra, and A. J. Dobson, Estimating the prevalence of dementia using multiple linked administrative health records and capture-recapture methodology, Emerg Themes Epidemiol, vol.14, p.3, 2017.

A. Rosenblum, M. Parrino, S. H. Schnoll, C. Fong, C. Maxwell et al., Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug and Alcohol Dependence. 6 sept, vol.90, pp.64-71, 2007.

C. Chenaf, J. Delorme, N. Delage, D. Ardid, A. Eschalier et al., Prevalence of chronic pain with or without neuropathic characteristics in France using the capture-recapture method: a population-based study, Pain. nov, vol.159, issue.11, pp.2394-402, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01926185

R. R. Regal and E. B. Hook, Goodness-of-fit based confidence intervals for estimates of the size of a closed population, Stat Med. sept, vol.3, issue.3, pp.287-91, 1984.

M. Chen, L. Huang, J. G. Ibrahim, and S. Kim, Bayesian Variable Selection and Computation for Generalized Linear Models with Conjugate Priors, Bayesian Anal. 1 juill, vol.3, issue.3, pp.585-614, 2008.

A. Der-heiden and M. , RECAP: Stata module to perform capture-recapture analysis for three sources with Goodness-of-Fit based confidence intervals

D. Sur,

E. Peles, S. Schreiber, J. Gordon, and M. Adelson, Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain, Pain. févr, vol.113, issue.3, pp.340-346, 2005.

E. J. Bartley and R. B. Fillingim, Sex differences in pain: a brief review of clinical and experimental findings, Br J Anaesth. juill, vol.111, issue.1, pp.52-60, 2013.

R. B. Fillingim, C. D. King, M. C. Ribeiro-dasilva, B. Rahim-williams, and J. L. Riley, Sex, gender, and pain: a review of recent clinical and experimental findings, J Pain. mai, vol.10, issue.5, pp.447-85, 2009.

G. S. Rovner, K. S. Sunnerhagen, A. Björkdahl, B. Gerdle, B. Börsbo et al., Chronic pain and sex-differences; women accept and move, while men feel blue, PLoS ONE, vol.12, issue.4, p.175737, 2017.

A. Tsang, V. Korff, M. Lee, S. Alonso, J. Karam et al., Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders, J Pain. oct, vol.9, issue.10, pp.883-91, 2008.

S. R. Savage and J. Schofferman, Pharmacological therapies of pain in drug and alcohol addictions, Pharmacological therapies for drug and alcohol addictions, pp.373-409, 1995.

Z. Z. Pan, Mechanisms of Opioid Tolerance, Zhuo M, éditeur. Molecular Pain, pp.413-435, 2007.

L. Roeckel, L. Coz, G. Gavériaux-ruff, C. Simonin, and F. , Opioid-induced hyperalgesia: Cellular and molecular mechanisms, Neuroscience. 3 déc, vol.338, pp.160-82, 2016.

P. Athanasos, W. Ling, F. Bochner, J. M. White, and A. A. Somogyi, Buprenorphine Maintenance Subjects Are Hyperalgesic and Have No Antinociceptive Response to a Very High Morphine Dose, Pain Med. janv, vol.20, issue.1, pp.119-147, 2019.

M. Doverty, J. M. White, A. A. Somogyi, F. Bochner, R. Ali et al., Hyperalgesic responses in methadone maintenance patients, Pain. 1 févr, vol.90, issue.1-2, pp.91-97, 2001.

J. L. Hay, J. M. White, F. Bochner, A. A. Somogyi, T. J. Semple et al., Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients, J Pain. mars, vol.10, issue.3, pp.316-338, 2009.

P. Compton, C. P. Canamar, M. Hillhouse, and W. Ling, Hyperalgesia in heroin dependent patients and the effects of opioid substitution therapy, J Pain. avr, vol.13, issue.4, pp.401-410, 2012.

P. Compton, V. C. Charuvastra, K. Kintaudi, and W. Ling, Pain responses in methadonemaintained opioid abusers, J Pain Symptom Manage, vol.20, issue.4, pp.237-282, 2000.

P. Compton, V. C. Charuvastra, and W. Ling, Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent, Drug Alcohol Depend. 1 juill, vol.63, issue.2, pp.139-185, 2001.

N. Richard, Psychiatric and Psychological Morbidities of Chronic Pain, Abd-Elsayed A, éditeur

, , pp.385-393, 2019.

S. Benjamin, S. Morris, J. Mcbeth, G. J. Macfarlane, and A. J. Silman, The association between chronic widespread pain and mental disorder: a population-based study, Arthritis Rheum. mars, vol.43, issue.3, pp.561-568, 2000.

F. G. Pereira, M. H. França, M. De-paiva, L. H. Andrade, and M. C. Viana, Prevalence and clinical profile of chronic pain and its association with mental disorders, Rev Saude Publica, vol.51, p.96, 2017.

P. H. Finan, B. R. Goodin, and M. T. Smith, The association of sleep and pain: An update and a path forward, J Pain. déc, vol.14, issue.12, pp.1539-52, 2013.

P. Haario, O. Rahkonen, M. Laaksonen, E. Lahelma, and T. Lallukka, Bidirectional associations between insomnia symptoms and unhealthy behaviours, J Sleep Res. févr, vol.22, issue.1, pp.89-95, 2013.

C. K. Burke, J. M. Peirce, M. S. Kidorf, D. Neubauer, N. M. Punjabi et al., Sleep problems reported by patients entering opioid agonist treatment, J Subst Abuse Treat, vol.35, issue.3, pp.328-361, 2008.

N. Breslau, T. Roth, L. Rosenthal, and P. Andreski, Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults, Biol Psychiatry. 15 mars, vol.39, issue.6, pp.411-419, 1996.

M. D. Stein, D. S. Herman, S. Bishop, J. A. Lassor, M. Weinstock et al., Sleep disturbances among methadone maintained patients, J Subst Abuse Treat. avr, vol.26, issue.3, pp.175-80, 2004.

E. Peles, S. Schreiber, and M. Adelson, Variables associated with perceived sleep disorders in methadone maintenance treatment (MMT) patients, Drug Alcohol Depend. 28 avr, vol.82, issue.2, pp.103-113, 2006.

S. L. Garnaat, R. B. Weisberg, L. A. Uebelacker, D. S. Herman, G. L. Bailey et al., The overlap of sleep disturbance and depression in primary care patients treated with buprenorphine, Subst Abus. déc, vol.38, issue.4, pp.450-454, 2017.

K. E. Dunn, P. H. Finan, A. Tompkins, D. Strain, and E. C. , Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients, Addict Behav. janv, vol.76, pp.8-14, 2018.

K. M. Berg, J. H. Arnsten, G. Sacajiu, and A. Karasz, Providers' experiences treating chronic pain among opioid-dependent drug users, J Gen Intern Med. avr, vol.24, issue.4, pp.482-490, 2009.

P. Courty and N. Authier, Douleur chez les patients dépendants aux opiacés, La Presse Médicale. déc, vol.41, issue.12, pp.1221-1226, 2012.

R. Bruce and . Mj, Opiophobia' Past and Present, 2012.

J. P. Morgan, American opiophobia: customary underutilization of opioid analgesics, Adv Alcohol Subst Abuse. Fall, vol.5, issue.1-2, pp.163-73, 1985.

S. M. Motov and A. N. Khan, Problems and barriers of pain management in the emergency department: Are we ever going to get better?, J Pain Res. 9 déc, vol.2, pp.5-11, 2008.

M. Zenz and A. Willweber-strumpf, Opiophobia and cancer pain in Europe, Lancet. 24 avr, vol.341, issue.8852, pp.1075-1081, 1993.

D. S. Bennett and D. B. Carr, Opiophobia as a barrier to the treatment of pain, J Pain Palliat Care Pharmacother, vol.16, issue.1, pp.105-114, 2002.

C. E. Keller, L. Ashrafioun, A. M. Neumann, J. Van-klein, C. H. Fox et al., Practices, perceptions, and concerns of primary care physicians about opioid dependence associated with the treatment of chronic pain, Subst Abus, vol.33, issue.2, pp.103-116, 2012.

, Worl Health Organization. Information sheet on opioid overdose

W. M. Compton, M. Boyle, and E. Wargo, Prescription opioid abuse: Problems and responses, Prev Med. nov, vol.80, pp.5-9, 2015.

A. Shei, J. B. Rice, N. Y. Kirson, K. Bodnar, H. G. Birnbaum et al., Sources of prescription opioids among diagnosed opioid abusers, Curr Med Res Opin. avr, vol.31, issue.4, pp.779-84, 2015.

B. St-marie, Health care experiences when pain and substance use disorder coexist: « just because i'm an addict doesn't mean i don't have pain », Pain Med. déc, vol.15, issue.12, pp.2075-86, 2014.

E. Eyler, Chronic and acute pain and pain management for patients in methadone maintenance treatment, Am J Addict. janv, vol.22, issue.1, pp.75-83, 2013.

E. Manguzzi, L. Wainstein, J. Desmeules, and B. Broers, Gestion de la douleur aiguë chez les patients sous traitements de substitution aux opioïdes. Revue Médicale Suisse

D. Sur,

D. P. Alford, P. Compton, and J. H. Samet, Acute pain management for patients receiving maintenance methadone or buprenorphine therapy, Ann Intern Med. 17 janv, vol.144, issue.2, pp.127-161, 2006.

J. Quinlan and F. Cox, Acute pain management in patients with drug dependence syndrome, Pain Rep. juill, vol.2, issue.4, p.611, 2017.

C. Victorri-vigneau, M. Guillou, M. Bronnec, M. Gérardin, C. Louvigné et al., Prise en charge de la douleur aiguë chez le patients sous traitement de substitution, Douleur Analg, vol.25, pp.83-89, 2012.

M. Mialou, J. Kauffmann, B. Richard, P. M. Llorca, P. Courty et al., Stratégies antalgiques et médicaments e de substitution aux opiacés, vol.12, pp.24-30, 2010.

N. Authier, P. M. Llorca, and P. Courty, Soulager la douleur chez les patients dépendants aux opiacés, Le courrier des addictions, vol.10, issue.4, pp.11-14, 2008.

A. J. Whitehead, S. K. Dobscha, B. J. Morasco, S. Ruimy, C. Bussell et al., Pain, substance use disorders and opioid analgesic prescription patterns in veterans with hepatitis C, J Pain Symptom Manage. juill, vol.36, issue.1, pp.39-45, 2008.

B. Brands, J. Blake, B. Sproule, D. Gourlay, and U. Busto, Prescription opioid abuse in patients presenting for methadone maintenance treatment, Drug Alcohol Depend. 7 févr, vol.73, issue.2, pp.199-207, 2004.

A. Fayaz, P. Croft, R. M. Langford, L. J. Donaldson, and G. T. Jones, Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies, BMJ Open. 6 janv, vol.6, issue.6, p.10364, 2016.

D. T. Barry, M. Beitel, B. Garnet, D. Joshi, A. Rosenblum et al., Relations among psychopathology, substance use, and physical pain experiences in methadone-maintained patients, J Clin Psychiatry. sept, vol.70, issue.9, pp.1213-1221, 2009.

M. Nicholas, J. Vlaeyen, W. Rief, A. Barke, Q. Aziz et al., The IASP classification of chronic pain for ICD-11: chronic primary pain, Pain. janv, vol.160, issue.1, pp.28-37, 2019.

R. Treede, W. Rief, A. Barke, Q. Aziz, M. I. Bennett et al., A classification of chronic pain for ICD-11, Pain. juin, vol.156, issue.6, pp.1003-1010, 2015.